Loading…

Poly(d,l-lactic-co-glycolic acid) (PLGA) hollow fiber with segmental switchability of its chains sensitive to NIR light for synergistic cancer therapy

[Display omitted] •AuNR-incorporated PLGA hollow fibers have been fabricated.•The fibers release pre-loaded anticancer drug in response to NIR light.•The on–off switching of NIR light allows a repeated dosing of the drug.•The on-demand release has a synergistic anticancer activity with PTT. This wor...

Full description

Saved in:
Bibliographic Details
Published in:Colloids and surfaces, B, Biointerfaces B, Biointerfaces, 2019-01, Vol.173, p.258-265
Main Authors: Choi, Ji Hyun, Seo, Hojun, Park, Ju Hyang, Son, Jin Ho, Kim, Da In, Kim, Jongbok, Moon, Geon Dae, Hyun, Dong Choon
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:[Display omitted] •AuNR-incorporated PLGA hollow fibers have been fabricated.•The fibers release pre-loaded anticancer drug in response to NIR light.•The on–off switching of NIR light allows a repeated dosing of the drug.•The on-demand release has a synergistic anticancer activity with PTT. This work introduces a new fibrous system for synergistic cancer therapy. The system consists of poly(d,l-lactic-co-glycolic acid) (PLGA) fibers with a core encapsulating an anticancer drug and a shell entrapping gold nanorods (AuNRs) as a photothermal agent. On exposure to NIR light, the photothermal agent generates heat to raise the local temperature of the fibers. If the temperature is above a glass transition (Tg) of the polymer, the polymer chains will be mobile, increasing free volume in size within the shell. As a result, a rapid release of the drug can be achieved. When NIR light is turned off, the release will stop with inactivity of the photothermal agent, followed by freezing the segmental motion of the polymer chains. The on–off switching of NIR light in a time-controllable manner allows a repeated and accurate release of the drug, leading to the significant enhancement of anticancer activity in combination with the hyperthermia effect arising from the photothermal agent.
ISSN:0927-7765
1873-4367
DOI:10.1016/j.colsurfb.2018.09.081